SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615219-18-000002
Filing Date
2018-01-12
Accepted
2018-01-12 15:52:19
Documents
3
Period of Report
2018-01-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-k.htm 8-K 30062
2 EXHIBIT 10.1 a101amendmenttwessel.htm EX-10.1 9838
3 companylogoa05.jpg GRAPHIC 10837
  Complete submission text file 0001615219-18-000002.txt   50781
Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 18525953
SIC: 2834 Pharmaceutical Preparations